Lobular Carcinoma in Situ(LCIS)by Amy Scholten, MPH DefinitionLobular carcinoma in situ (LCIS) is when there are abnormal cells in the lobules of the breast. The lobules are the part of the breast that produces milk. LCIS is not cancer. However, it can raise the risk of future breast cancer. CausesIt is not clear what causes LCIS. It is likely due to a change in a gene. Risk FactorsLCIS is more common in premenopausal women between 40 to 50 years old. SymptomsLCIS does not have symptoms. DiagnosisLCIS does not appear on imaging tests. It cannot be felt during a breast exam. It is usually found during a biopsy of other nearby breast tissue. TreatmentLCIS does not require treatment. The doctor will monitor the breast for changes with:
PreventionThe risk of breast cancer may be reduced by:
RESOURCES:American Cancer Society https://www.cancer.org National Cancer Institute https://www.cancer.gov References:LCIS—lobular carcinoma in situ. Breast Cancer website. Available at: ...(Click grey area to select URL) Accessed March 19, 2021.
Lobular carcinoma in situ. EBSCO DynaMed website. Available at:
https://www.dynamed.com/condition/lobular-carcinoma-in-situ. Accessed March 19, 2021.
Lobular carcinoma in situ (LCIS). American Cancer Society website. Available at: https://www.cancer.org/cancer/breast-cancer/non-cancerous-breast-conditions/lobular-carcinoma-in-situ.html. Accessed March 19, 2021. Wen HY, Brogi E. Lobular carcinoma in situ. Surg Pathol Clin. 2018;11(1):123-145. Last reviewed January 2021 by
EBSCO Medical Review Board
Mohei Abouzied, MD, FACP Last Updated: 3/19/2021 |
|
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. |